Please login to the form below
acute coronary syndrome
This page shows the latest acute coronary syndrome news and features for those working in and with pharma, biotech and healthcare.
AstraZeneca’s Farxiga scores another FDA fast-track designation
or cardiovascular death in adult following an acute myocardial infarction or heart attack. ... In addition to Farxiga, AZ also has Brilinta (ticagrelor) in its cardiovascular, renal and metabolism (CVRM) franchise, which is approved for the treatment of
Latest news
-
AstraZeneca’s Brilinta reduces rate of secondary stroke
The drug is already approved for the treatment of acute coronary syndrome (ACS) and for the secondary prevention of cardiovascular events among high-risk patients who have experienced a heart attack. ... who have previously experienced an acute ischaemic
-
AZ says Brilinta hits the mark in new stroke trial
Results of the phase 3 THALES trial showed Brilinta, in combination with aspirin, improved outcomes in patients who had experienced a minor acute ischaemic stroke or high-risk transient ischaemic attack. ... The drug is already approved for the treatment
-
AZ unveils phase 3 Brilinta data in CAD and type 2 diabetes
In addition, the drug also demonstrated a 15% relative risk reduction in patients who had previously undergone a percutaneous coronary intervention (PCI), a procedure to open a blocked or narrowed coronary ... Brilinta is already approved to reduce the
-
AZ says Brilinta hits the mark in diabetic heart disease
territory. Meanwhile, next year, AZ is also expecting a phase 3 readout in the THALES trial of Brilinta as a treatment for in acute ischemic stroke and transient ischaemic attack, that ... patients undergoing interventions for acute coronary syndrome (ACS
-
Cancer drugs and China sustain AZ’s return to growth
antiplatelet drug Brilinta (ticagrelor) rose 22% to $1.32bn thanks to continued market penetration in the treatment of acute coronary syndrome (ACS) and high-risk post-myocardial infarction patients.
More from news
Approximately 7 fully matching, plus 52 partially matching documents found.
Latest Intelligence
-
Why health psychology is the answer to tackling adherence
In one recent programme that we developed on behalf of AstraZeneca, we assessed the reasons for low adherence in patients with acute coronary syndrome (ACS) who had been prescribed Oral Antiplatelet
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest appointments
-
AZ names Brilique lead in Spain
In this role Gribble will be responsible for the company's marketing of Brilique (ticagrelor) for acute coronary syndrome, including management, development and market access activities, and he will also be ... to save the lives of thousands of people
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Understanding the "Big Picture"
A good example would be in acute coronary syndrome (ACS) where there is data to suggest that approximately 350, 000 males in the USA currently suffer from this syndrome.
More from PMHub
Approximately 1 fully matching, plus 0 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- New study identifies drugs that are safe to use in COVID-19 treatment
- BioNTech bolsters COVID-19 vaccine capacity with Novartis deal
- Regeneron launches phase 3 COVID-19 antibody trial in the UK
- 20 for 2020 – Five pharma companies to watch
- Leadership change within Bedrock Group
- Moderna inks R&D agreements with Vertex and Chiesi
- OPEN Health’s Digital team have won a Bronze Award at the PM Society Digital Awards 2020
- New restrictions announced as UK’s COVID-19 alert level is increased
- Keytruda plus chemotherapy cuts risk of death by 27% in advanced oesophageal cancer
- AZ/Merck's Lynparza improves survival in certain prostate cancers
- The flexible salesforce
- Navigating engagement and remote working during the pandemic
PMHub
Streaming Well
Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual...
Latest intelligence
- Improve clinical trials through patient journey mapping
- Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...
- InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
- Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
- Alone we can do so little, together we can do so much
- Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
Quick links
Infographics
